Showing results (1101-1110 of 2,199) with videos related to
Sort By:
Pageof 220
Developments in Biological Standardization|January 1, 1979
Benefit-cost and cost-effectiveness analysis: theory and applicationN J McCarthyDevelopments in Biological Standardization|January 1, 1985
Production in yeast of hepatitis B surface antigen by R-DNA technologyM De Wilde, T Cabezon, N Harford, et al.Developments in Biological Standardization|January 1, 1985
A serum independent medium effective in all aspects of hybridoma technology and immunological applicationsP Baker, K Knoblock, L Noll, et al.Developments in Biological Standardization|January 1, 1976
One year experience on the Lindholm B medium used in large--scale FMD virus production on BHK cells in suspensionM H Jensen, F O SoerensenDevelopments in Biological Standardization|January 1, 1990
Immunopathogenesis of equine infectious anemia lentivirus diseaseT C McGuire, K I O'Rourke, L E PerrymanDevelopments in Biological Standardization|January 1, 1987
Alternatives for harvesting cells grown on microcarriers: effects on subsequent attachment and growthU Lindskog, B Lundgren, D Billig, et al.Developments in Biological Standardization|January 1, 1976
The cultivation of BHK monolayer cells on DEAE Sephadex A50 beads maintained in suspensionJ P Whiteside, R E SpierDevelopments in Biological Standardization|January 1, 1986
Attempts for replacement of asparagine in Sauton's medium by some organic acids in the production of PPD-tuberculinsN Kirilov, M Petkov, Y YolovDevelopments in Biological Standardization|January 1, 1985
Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young childrenD Miller, J Wadsworth, J Diamond, et al.Developments in Biological Standardization|January 1, 1985
Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patientsS Isomura, S Suzuki, Y SatoPageof 220